ClinicalTrials.gg
Sign In

Vitreoretinopathy, Proliferative clinical trials

The registry lists 43 studies for Vitreoretinopathy, Proliferative across more than 10 countries. 11 are recruiting or about to start. 25 of them are mainly about Vitreoretinopathy, Proliferative (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Vitreoretinopathy, Proliferative studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
18
Status unknown
11
Recruiting
6
Not yet recruiting
4
Withdrawn
2
Enrolling by invitation
1

Phase

Phase 2
12
Phase 3
11
Phase 1
4
Phase 4
3
Early Phase 1
1

Where

United States
12
Iran, Islamic Republic of
6
Egypt
4
Canada
3
Indonesia
2
United Kingdom
2

Who runs them

Shahid Beheshti University of Medical Sciences (6) · Wills Eye (3) · University College, London (2) · Central Hospital, Nancy, France (2) · Massachusetts Eye and Ear Infirmary (2) · Benha University (2) · Unity Health Toronto (2) · Ahalia Foundation Eye Hospital (1)

What is being tested here

Drugs under test in Vitreoretinopathy, Proliferative studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Methotrexate225
Topotecan202
Netarsudil112
Triamcinolone013
Triamcinolone Acetonide012
Bevacizumab002
Colchicine022
Heparin, Low-Molecular-Weight022
Fluorouracil022
Enoxaparin sodium001

Drug classes tested here Antimetabolites 2 open · Corticosteroids 4 · Angiogenesis inhibitors 3

Coming up

0phase 3 studies under way
4studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 4

Who these studies take

Of the 6 Vitreoretinopathy, Proliferative studies recruiting now, 5 (83%) set no upper age limit and 1 (17%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (17%) take healthy volunteers.

Recruiting studies that take each age, of 6
AgeWomenMen
100 (0%)0 (0%)
185 (83%)5 (83%)
306 (100%)6 (100%)
406 (100%)6 (100%)
506 (100%)6 (100%)
656 (100%)6 (100%)
755 (83%)5 (83%)
855 (83%)5 (83%)

Across all 43 studies, recruiting or not: 14% stop at 75 or younger and 12% at 65; 14% take children; 0% are for women only and 5% for men only; 14% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

What changed recently

From the registry's own updates since Oct 13, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 43 of 43. search them.